The Globe and Mail reports in its Friday, Oct. 31, edition that TD Cowen analyst Brian Morrison has reaffirmed his "buy" recommendation for Gildan Activewear. The Globe's David Leeder writes in the Eye On Equities column that Mr. Morrison boosted his share target by a buck to $74 (all figures U.S.). Analysts on average target the shares at $71.10. Mr. Morrison says in a note: "The Q3/25 results were in line, but more important, we view the HBI acquisition as the key catalyst. Combining the brand strength of HBI with Gildan's low-cost advantage/innovation should support attractive innerwear share gains. Further benefits from material cost synergies, debt refinancing, strong FCF and a sale of non-core assets should accelerate Gildan's standalone EPS growth outlook." The Globe reported on Oct. 17, 2024, and Sept. 9, 2025, that Mr. Morrison continued to rate Gildan Activewear "buy." The shares were then worth $47.41 and $54.92. The Globe reported on Oct. 28, 2025, that RBC Capital Markets analyst Ryland Conrad was keeping his "outperform" ranking for Gildan Activewear intact. The shares were then going for $61.26.